Rchr
J-GLOBAL ID：202001019788368460
Update date: Feb. 22, 2024
Kameoka Yosuke
カメオカ ヨウスケ | Kameoka Yosuke
Affiliation and department：
Job title：
中央研究所長
Research keywords (2)：
Antibody drug
, Genomics
Research theme for competitive and other funds (3)：
- 2008 - 2011 Construction of artificial poly-clonal gamma globulin to control HCV infection and development of assay system
- 2004 - 2005 In vivo imaging and molecular mechanism analysis at initial phase of vasculitis development
- 1993 - 1995 To establish the method for estimate the late effect induced by local irradiation therapy by detecting chromosomal aberration of peripheral blood lymphocytes
Papers (57)：
-
Minako Koura, Yosuke Kameoka, Fukuko Kishi, Yoshio Yamakawa, Fuyu Ito, Ryuichi Sugamata, Yuko Doi, Kazuko Uno, Toshinori Nakayama, Takashi Miki, et al. Enhanced efficacy of the novel recombinant clone VasSF in a mouse model of antineutrophil cytoplasmic antibody-associated vasculitis. Clinical and experimental immunology. 2023
-
Fuyu Ito, Toshiaki Oharaseki, Daisuke Tsukui, Yoshitaka Kimura, Tamiko Yanagida, Fukuko Kishi, Yoshio Yamakawa, Yosuke Kameoka, Shoichi Suzuki, Kazuko Uno, et al. Beneficial effects of anti-apolipoprotein A-2 on an animal model for coronary arteritis in Kawasaki disease. Pediatric rheumatology online journal. 2022. 20. 1. 119-119
-
Minako Koura, Yuko Doi, Fukuko Kishi, Yosuke Kameoka, Yoshio Yamakawa, Rora Nagasawa, Fuyu Ito, Yasutomo Hamano, Kazuo Suzuki, Osamu Suzuki. VasSF treatment increased the number of pup deliveries per female in SCG/Kj mice. 2021. 8. 1
-
Yoshitomo Hamano, Fuyu Ito, Osamu Suzuki, Minako Koura, Shuji Matsuoka, Toshiyuki Kobayashi, Yoshinobu Sugitani, Nadila Wali, Ai Koyanagi, Okio Hino, et al. Vasculitis and crescentic glomerulonephritis in a newly established congenic mouse strain derived from ANCA-associated vasculitis-prone SCG/Kj mice. Autoimmunity. 2019. 52. 5-6. 208-219
-
Yosuke Kameoka, Fukuko Kishi, Minako Koura, Yoshio Yamakawa, Rora Nagasawa, Fuyu Ito, Junichiro Matsuda, Osamu Suzuki, Toshinori Nakayama, Kazuo Suzuki. Efficacy of a recombinant single-chain fragment variable region, VasSF, as a new drug for vasculitis. Drug design, development and therapy. 2019. 13. 555-568
ｍore...
MISC (31)：
-
橋本香保子, 橋本香保子, 小浦美奈子, 鈴木治, 伊藤吹夕, 亀岡洋祐, 中山俊憲, 鈴木和男, 鈴木和男. Bioimaging analysis of an anti-vasculitis therapeutic drug (VasSF) in a mouse model: From the perspective of the severity analysis of COVID-19. バイオイメージング. 2022. 31. 2
-
濱野慶朋, 伊藤吹夕, 小林巧, 池尾一穂, 湯村和子, 丸山直記, 亀岡洋祐, 鈴木和男. SCG/KjマウスにおけるANCA産生・腎炎素因遺伝子の解析:RNA-Sequenceによる知見. 日本腎臓学会誌(Web). 2021. 63. 4
-
Fuyu Ito, Minako Koura, Shoichi Suzuki, Toshiko Tsurumi, Fukuko Kishi, Kazuko Uno, Yosuke Kameoka, Osamu Suzuki, Kazuo Suzuki. MOESIN EXPRESSION LEVEL OF MPO-ANCA ASSOCIATED-VASCULITIS MODEL MICE. RHEUMATOLOGY. 2019. 58
-
Yosuke Kameoka, Fukuko Kishi, Minako Koura, Yoshio Yamakawa, Rora Nagasawa, Fuyu Ito, Junichiro Matsuda, Osamu Suzuki, Toshinori Nakayama, Kazuo Suzuki. NEW DRUG FOR VASCULITIS: EFFICACY OF A RECOMBINANT SINGLE-CHAIN FRAGMENT VARIABLE REGION, VASSF. RHEUMATOLOGY. 2019. 58. 158-158
-
Oharaseki Toshiaki, Kameoka Yosuke, Miura Noriko, Ohno Naohito, Suzuki Kazuo, Takahashi Kei. Administration of recombinant single chain fragment of variable region (hScFv) of IgG suppresses development of murine vasculitis induced with Candida albicans water-soluble fraction: An animal model of Kawasaki disease. ADC Letter for Infectious Disease Control. 2019. 6. 2. 51-55
ｍore...
Return to Previous Page
